Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelioid Hemangioendothelioma (EHE)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT07104331
What this trial is testing

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

Who this might be right for
Epithelioid Hemangioendothelioma (EHE)
Sarcoma Alliance for Research through Collaboration 41
Early research (Phase 1)Ended earlyNCT05228015
What this trial is testing

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Who this might be right for
Solid Tumors, AdultSolid TumorMalignant Pleural Mesothelioma (MPM)+5 more
Ikena Oncology 67
Testing effectiveness (Phase 2)Study completedNCT03331250
What this trial is testing

Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

Who this might be right for
AngiosarcomaEpithelioid Hemangioendothelioma
Massachusetts General Hospital 13
Early research (Phase 1)Looking for participantsNCT06452160
What this trial is testing

BGC515 Capsules in Subjects With Advanced Solid Tumors

Who this might be right for
MesotheliomaEpithelioid Hemangioendothelioma(EHE)Solid Tumor
BridGene Biosciences Inc. 103